Ulta Beauty Inc (NASDAQ: ULTA) Gets A 20.64% Target Price Upside From Analysts While 7.61% Above Its 52-Week Low

Ulta Beauty Inc (NASDAQ:ULTA) does about 856.39K shares in volume on a normal day but saw 643889 shares change hands in the recent trading day. The company now has a market cap of 18.90B USD. Its current market price is $396.01, marking an increase of 0.05% compared to the previous close of $395.82. The 52 week high reached by this stock is $574.76 whilst the lowest price level in 52 weeks is $368.02. The script in recent trading has seen the stock touch a high of $630 and a low of $393.

Ulta Beauty Inc (ULTA) has a 20-day trading average at $388.40 and the current price is -31.10% off the 52-week high compared with 7.61% distance from its 52-week low. The 50-day simple moving average of the closing price is $390.99 and its 200-day simple moving average is $444.10. If we look at the stock’s price movements over the week, volatility stands at 2.29%, which decreases to 1.98% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 55.94 to suggest the stock is neutral.

The consensus objective for the share price is $481.24, suggesting that the stock has a potential upside of 17.71% over the period. The median price target is 20.64% away from the current levels at $499.

10 analysts have rated it as a buy and 6 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Moderate Buy the stock.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on May 24, 2024 when Telsey Advisory Group reiterated the stock to “Outperform” and issued a price target of between $600 and $500. Barclays downgraded the stock to “Equal Weight” from Overweight on April 29, 2024 at a price target of $612-$434. Jefferies downgraded its price target at $585-$438.

Ulta Beauty Inc (ULTA) stock is up 3.02% over the week and 2.89% over the past month. Its price is -19.18% year-to-date and -16.03% over the past year.

The stock last released its quarterly earnings report for quarter ended 4/30/2024, with the company’s earnings per share (EPS) of 6.02 above consensus estimates by 0.17. The company’s next earnings report forecasts estimating quarterly EPS at 5.55 and 25.76 for whole year. Expected sales for next quarter are $2.62B, which analysts say will come at $11.56B for the current fiscal year and next year at $12.25B. In addition, estimates put the company’s current quarterly revenue at an average of $2.63B.

Its 12-month price target is $499. To reach the target analysts have set, the stock logically needs to grow 17.71 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $393, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $630.

Outstanding shares total 48.32M with insiders holding 0.21% of the shares and institutional holders owning 97.42% of the company’s common stock. The company has a return on investment of 32.16% and return on equity of 58.21%. The price to earnings ratio (P/E ratio) amounts to 15.44 while the forward price to earnings ratio is 14.02. The beta has a value of 1.37. Price to book ratio is 8.24 and price to sales ratio is 1.67.